Sat, Dec 27, 2014, 4:29 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

  • solantey@sbcglobal.net solantey Jun 11, 2006 11:54 PM Flag

    Must Read for Potential Investors

    Monday will be the first trading session after the 30 day wash period expired on Friday. The old shareholders that have been on the sidelines waiting to re-enter will be buying. ELN (in a similar situation last year) went up 65% in a few trading sessions after the wash period ended.

    Once the share price moves above the $5.00 price level many funds will be able to purchase shares that are currently unable to do so. I also expect upgrades from one or two major brokerages will happen in the short term.

    The company has $85,000,000 in cash, no debt, and three drugs in development with a potential market of over $6 billion. The company has funds to operate for the next 18 months.

    Morgan Stanley, which had a $25.00 price target on the stock, said that one of the drugs could become the "Gold Standard" for treating enlarged prostrates. The potential market for that one drug alone is $3 billion.

    The other drug treats pancreatic cancer and was just recommended by an independent committee to be allowed to proceed to phase 3 trials. This drug alone justifies a share price in excess of the current share price.

    On June 1 the company received the formal letter from the F.D.A. and it is in the process of preparing its� response. At the Bank of America Health Care Conference the C.O.O. of Threshold stated that the company �fully expects� the trial to resume. The drug has already been approved in Europe and it is believed that the elevated liver enzymes are , in a woesrt case scenario simply a dosing issue and in the most likely scenario due to outside factors totally unrelated to the drug such as chronic alcoholism.

    A partnership or a buyout is quite likely.

    Visit "stockconsultant,com" and notice it now has a "100% bullish" summary rating on the stock with a short term price target of $5.36. Also it�s trade quality at 95% to the �upside� is the highest its� been since the drop in the share price.

    h**p://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=thld#ttop

    Visit the company�s website to obtain more specific information.

    h**p://www.thresholdpharm.com/


    Realistic Price is $15.00 by Christmas.

 
THLD
3.04+0.11(+3.75%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST